Ebasone, Peter Vanes
Dzudie, Anastase
Peer, Nasheeta
Hoover, Donald
Shi, Qiuhu
Kim, Hae-Young
Brazier, Ellen
Ajeh, Rogers
Yotebieng, Marcel
Nash, Denis
Anastos, Kathryn
Kengne, Andre Pascal
Funding for this research was provided by:
EDCTP2 programme (TMA2017 GSF- 1962- CaDERAL, TMA2017 GSF- 1962- CaDERAL, TMA2017 GSF- 1962- CaDERAL)
National Institutes of Health’s National Institute of Allergy and Infectious Diseases (U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA), U01AI096299 (Central Africa-IeDEA))
Article History
Received: 6 September 2023
Accepted: 22 May 2024
First Online: 1 June 2024
Declarations
:
: Ethical approval for the study was obtained from the Comité National Pour La Recherche en Sante Humaine (CNERSH) in Cameroon. Informed consent was obtained from all participants involved in the study.
: Not applicable.
: The authors declare that they have no competing interests.